| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 47,746 | 50,627 | 50,448 | 51,324 | | Cost of Revenue | 27,078 | 28,029 | 28,617 | 30,515 | | | Gross Profit | 20,668 | 22,598 | 21,831 | 20,809 | | | Operating Expenses | | Research Development | 7,831 | 7,611 | 7,751 | 8,006 | | Selling General and Administrative | 11,751 | 15,976 | 12,823 | 14,476 | | Non Recurring | (379) | (3,098) | 3,098 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,932 | 2,109 | (1,841) | (1,673) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 718 | 193 | 118 | 87 | | Earnings Before Interest And Taxes | 2,183 | 2,302 | (1,723) | (1,951) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 2,183 | 2,302 | (1,723) | (1,951) | | Income Tax Expense | 193 | 544 | 428 | 911 | | Minority Interest | (299) | (417) | (392) | (365) | | | | Net Income From Continuing Ops | 1,691 | 1,341 | (2,543) | (3,501) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,691 | 1,341 | (2,543) | (3,501) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,691 | $1,341 | ($2,543) | ($3,501) |
|
0.03% Nasdaq 
0.01 (0.11%) 
Income Statement
